European Archives - Page 26 of 1486 - European Medical Journal

Lumbar Spine Bone Loss Linked to Glucocorticoid Treatment

Low-dose glucocorticoid treatment caused modest lumbar spine bone loss in rheumatoid arthritis over two years, a meta-analysis finds.

Tildrakizumab Improves Quality of Life in Plaque Psoriasis

A real-world study found tildrakizumab improved skin clearance, symptoms, and quality of life in adults with plaque psoriasis.

Theta Burst Stimulation for Placebo-Induced Mood Improvement

Theta burst stimulation enhanced placebo-driven mood improvement and brain network activity in adults with depressive symptoms.

AI Models Predict Low Risk DCIS Features

Deep learning models accurately predicted key DCIS biomarkers from pathology slides, supporting active surveillance strategies.

Plasmodium vivax Malaria Detected in Duffy-Negative Hosts

Plasmodium vivax malaria found in Duffy-negative individuals in Sudan, challenging assumptions about resistance and revealing parasite adaptation. Read more.

Ruchi Gupta

Prevention, Precision and Policy: Interview with Ruchi Gupta

When I began my career in Chicago, USA, my research was centred on asthma, a condition that affects so many children every day, but one…

Ramzi Khamis

From Plaque to Patient: Interview with Ramzi Khamis

There were several defining moments, but perhaps the deepest influence was growing up between Jerusalem and Bethlehem, where one becomes…

Targeting PELI1 In Chronic Myeloid Leukaemia

Targeting PELI1 in chronic myeloid leukaemia may overcome treatment resistance and eliminate leukaemia stem cells, offering a promising new therapeutic strategy.

Egg Allergy Testing May Improve Diagnosis in Children - EMJ

Mast Cell Activation Test May Improve Paediatric Egg Allergy Diagnosis

A new study explores how mast cell activation and IgE function could improve diagnosis of baked and loosely cooked egg allergy in children.

One Colonoscopy Cut Cancer Incidence but Not Mortality After 13 Years

One colonoscopy can significantly reduce colorectal cancer incidence but not mortality, according to an ongoing long-term randomised controlled trial.